ATXI: Biji pasar avenuetx.com

Avenue Therapeutics develops therapies for CNS pathologies, focusing on the hospital segment and the fight against opioid addiction. The team brings together leading neurologists to whom the firm provides resources and scientific autonomy. The asset's market capitalization stands at 0.00, while the business operates in an autonomous cycle independent of macroeconomics. This daily price chart for (ATXI) is presented below.

Avenue Therapeutics, Inc. - Kapitalisasi pasar ATXI (periode 04.07.2022 - 29.03.2025)

ATXI (Avenue Therapeutics Inc): rincian analitis lan laporan miturut indikator

Ringkesan indikator lan parameter pambiji Avenue Therapeutics (ATXI):

Kutipan saham Avenue Therapeutics, Inc.|ATXI - Rega prakiraan analis|Biji pasar Avenue Therapeutics Inc

Analisis fundamental perusahaan:ATXI (Avenue Therapeutics, Inc.)

Sampel barang avenuetx.com

Avenue Therapeutics (ATXI) neurological drug development is sensitive to the stability of global chemical component supply chains. Analyzing the company's market capitalization chart allows for tracking the market reaction to geopolitical risks. This indicator is calculated as the product of the current share price and the total number of outstanding securities. This metric reflects aggregate investor expectations rather than the intrinsic value of the assets. A sharp increase in valuation may signal that the asset is overbought amid inflated forecasts.

Pesaing wigati

Biogen - Biji pasar|Nilai pasar NBIX (Neurocrine)|RGC: Biji pasar|AXSM (Axsome Corp) - Kapitalisasi pasar|ACAD: Kapitalisasi pasar|XENE - Kapitalisasi pasar|Nilai pasar Viking Therapeutics, Inc.|Kapitalisasi pasar SUPN (Supernus Pharmaceuticals, Inc.)|Kapitalisasi pasar CPRX|DNLI - Nilai pasar|Harmony Biosciences - Biji pasar|Kapitalisasi pasar biohavenpharma.com BHVN|AMLX - Nilai pasar|Nilai pasar TRVI (Trevi Therapeutics Inc)|Praxis Medicines (PRAX) - Nilai pasar|Nilai pasar Anavex Life Sciences Corp (AVXL)|CBLL (CeriBell, Inc.) - Kapitalisasi pasar|Kapitalisasi pasar Prothena Corp|Biji pasar ALEC (Alector, Inc.)|Nilai pasar ANNX (Annexon Biosciences)|Kapitalisasi pasar OMER (Omeros)|Neurogene Therapeutics (NGNE) - Nilai pasar|ACIU - Nilai pasar|VYGR (voyagertherapeutics.com) - Kapitalisasi pasar|NMRA (Neumora Therapeutics, Inc.) - Biji pasar|Scilex Holding (SCLX) - Kapitalisasi pasar|TVGN (Tevogen Bio Holdings, Inc.) - Kapitalisasi pasar|Nilai pasar Alpha Cognition Corp ACOG|Biji pasar CGTX (Cognition Therapeutics, Inc.)|IKT (inhibikase.com) - Nilai pasar|Cassava Sciences - Biji pasar|Nilai pasar ASRT (Assertio Holdings)|Coya - Kapitalisasi pasar|Nilai pasar VTGN (Vistagen Therapeutics)|OVID: Kapitalisasi pasar|Nilai pasar acumenpharm.com (ABOS)|Nilai pasar CervoMed|ATHE: Nilai pasar|Kapitalisasi pasar CLNN|Kapitalisasi pasar pepgen.com (PEPG)|Nilai pasar Jupiter Neurosciences JUNS|RLMD (relmada.com) - Biji pasar|Annovis Bio - Kapitalisasi pasar|Nilai pasar Grace Therapeutics, Inc.|AIFF (Firefly Neuroscience Inc) - Biji pasar|Klotho Neurosciences (KLTO) - Kapitalisasi pasar|Biji pasar NRSN|RVPH (revivapharma.com) - Nilai pasar|Kapitalisasi pasar MTVA|Kapitalisasi pasar NeurAxis Inc.|Kapitalisasi pasar HSDT (Helius Medical Technologies)|PASG - Biji pasar|NEUP - Nilai pasar|Kapitalisasi pasar minervaneurosciences.com NERV|ATHA: Kapitalisasi pasar|Addex Therapeutics Ltd. (ADXN) - Kapitalisasi pasar|Biji pasar ALZN|CYCN (Cyclerion) - Nilai pasar|Biji pasar PTIX (Protagenic Therapeutics)|pasitheaclinics.com - Kapitalisasi pasar|Kapitalisasi pasar CRGT (Cortigent)|Kapitalisasi pasar Brainstorm Cell Therapeutics Inc. (BCLI)|CARA - Nilai pasar|CHRO (Chromocell) - Kapitalisasi pasar|ELYM: Kapitalisasi pasar|Nilai pasar Intra-Cellular Therapies, Inc. (ITCI)|Biji pasar LBPH|Kapitalisasi pasar Marinus Pharmaceuticals Inc|Nilai pasar NKGen (NKGN)|NRBO (NeuroBo Pharma) - Nilai pasar|Nilai pasar Sage Therapeutics, Inc. SAGE|synaptogen.com (SNPX) - Nilai pasar|Trevena - Kapitalisasi pasar|VIGL - Kapitalisasi pasar|WENA (Anew Medical, Inc.) - Biji pasar|CERE (Cerevel Corp) - Nilai pasar